TNFSF10 and atherosclerosis: Apart from predicting the outcome and therefore serving as a risk marker, TRAIL is considered to participate in the pathogenesis of various CVDs, including heart failure, atherosclerosis, coronary artery disease, atrial fibrillation (AF), and stroke.